J Dent Res:血清淀粉样蛋白A通过TLR2和TLR4促进慢性根尖周炎的发生

2018-09-22 lishiting MedSci原创

在现代细菌感染理念中,一直认为来源于病原体的病原相关分子模式(PAMPs)和来源于损伤/坏死宿主细胞的损伤相关分子模式(DAMPs)是诱导固有免疫反应的主要因素。然而,DAMPs在根尖周炎及边缘牙周炎中的作用还未可知。血清淀粉样蛋白A (SAA)是一种DAMP,它涉及多种慢性炎症性疾病的发展,如风湿性关节炎。在这篇研究中,作者利用人的尖周手术样本以及SAA和Toll-like receptors

在现代细菌感染理念中,一直认为来源于病原体的病原相关分子模式(PAMPs)和来源于损伤/坏死宿主细胞的损伤相关分子模式(DAMPs)是诱导固有免疫反应的主要因素。然而,DAMPs在根尖周炎及边缘牙周炎中的作用还未可知。血清淀粉样蛋白A (SAA)是一种DAMP,它涉及多种慢性炎症性疾病的发展,如风湿性关节炎。在这篇研究中,作者利用人的尖周手术样本以及SAA和Toll-like receptors (TLR)缺陷小鼠检测了SAA是否涉及到尖周损伤的发病机制中。

结果显示,SAA1/2在mRNA和蛋白水平上均局部表达于人尖周损伤内。SAA蛋白表达水平与损伤处的炎症程度正相关。在小鼠尖周炎症进展过程中,SAA1.1/2.1在野生小鼠(WT)的局部及全身均表达上调。虽然SAA1.1/2.1双敲和SAA3敲除小鼠表现出根尖周病变程度的明显减少,但这些小鼠与WT相比出现明显增多的炎症细胞浸润。重组人SAA1 (rhSAA1)在体外以剂量依赖的方式直接诱导WT嗜中性粒细胞的趋药性。并且,施加rhSAA1刺激会显著延长WT嗜中性粒细胞的存活。此外,rhSAA1会激活NF-κB通路,并以剂量依赖的方式促进巨噬细胞内IL-1α的产生。然而,TLR2/TLR4双敲明显减弱SAA介导的促炎症反应。

总的来说,SAA-TLR轴通过诱导炎症细胞浸润和延长细胞存活对慢性尖周炎症的形成发挥着重要作用。而PAMPs和DAMPs在牙齿/口腔炎症中的相互作用还需要进一步的研究。

原始出处

Hirai K, Furusho H, et al. Serum Amyloid A Contributes to Chronic Apical Periodontitis via TLR2 and TLR4. J Dent Res. 2018 Sep 6:22034518796456. doi: 10.1177/0022034518796456.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1967954, encodeId=a01a196e95417, content=<a href='/topic/show?id=b8fe1e53318' target=_blank style='color:#2F92EE;'>#TLR2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17533, encryptionId=b8fe1e53318, topicName=TLR2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Feb 24 07:57:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746618, encodeId=29961e4661886, content=<a href='/topic/show?id=989d1e525e5' target=_blank style='color:#2F92EE;'>#TLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17525, encryptionId=989d1e525e5, topicName=TLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd2d35803070, createdName=lilianxiang, createdTime=Wed Aug 21 12:57:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380219, encodeId=b402138021988, content=<a href='/topic/show?id=48786219204' target=_blank style='color:#2F92EE;'>#根尖周炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62192, encryptionId=48786219204, topicName=根尖周炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcae472, createdName=zhangbaojun, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390030, encodeId=7a33139003064, content=<a href='/topic/show?id=2de31e53537' target=_blank style='color:#2F92EE;'>#TLR4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17535, encryptionId=2de31e53537, topicName=TLR4)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F39C49DDAFA7119F6BF29B57B788FE2C/100, createdBy=0ca42500047, createdName=ms3875500703114551, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442852, encodeId=f4101442852ac, content=<a href='/topic/show?id=e112659308a' target=_blank style='color:#2F92EE;'>#淀粉样蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65930, encryptionId=e112659308a, topicName=淀粉样蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1774999170, createdName=ms7405317358118777, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
    2019-02-24 仁医06
  2. [GetPortalCommentsPageByObjectIdResponse(id=1967954, encodeId=a01a196e95417, content=<a href='/topic/show?id=b8fe1e53318' target=_blank style='color:#2F92EE;'>#TLR2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17533, encryptionId=b8fe1e53318, topicName=TLR2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Feb 24 07:57:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746618, encodeId=29961e4661886, content=<a href='/topic/show?id=989d1e525e5' target=_blank style='color:#2F92EE;'>#TLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17525, encryptionId=989d1e525e5, topicName=TLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd2d35803070, createdName=lilianxiang, createdTime=Wed Aug 21 12:57:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380219, encodeId=b402138021988, content=<a href='/topic/show?id=48786219204' target=_blank style='color:#2F92EE;'>#根尖周炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62192, encryptionId=48786219204, topicName=根尖周炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcae472, createdName=zhangbaojun, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390030, encodeId=7a33139003064, content=<a href='/topic/show?id=2de31e53537' target=_blank style='color:#2F92EE;'>#TLR4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17535, encryptionId=2de31e53537, topicName=TLR4)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F39C49DDAFA7119F6BF29B57B788FE2C/100, createdBy=0ca42500047, createdName=ms3875500703114551, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442852, encodeId=f4101442852ac, content=<a href='/topic/show?id=e112659308a' target=_blank style='color:#2F92EE;'>#淀粉样蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65930, encryptionId=e112659308a, topicName=淀粉样蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1774999170, createdName=ms7405317358118777, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
    2019-08-21 lilianxiang
  3. [GetPortalCommentsPageByObjectIdResponse(id=1967954, encodeId=a01a196e95417, content=<a href='/topic/show?id=b8fe1e53318' target=_blank style='color:#2F92EE;'>#TLR2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17533, encryptionId=b8fe1e53318, topicName=TLR2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Feb 24 07:57:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746618, encodeId=29961e4661886, content=<a href='/topic/show?id=989d1e525e5' target=_blank style='color:#2F92EE;'>#TLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17525, encryptionId=989d1e525e5, topicName=TLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd2d35803070, createdName=lilianxiang, createdTime=Wed Aug 21 12:57:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380219, encodeId=b402138021988, content=<a href='/topic/show?id=48786219204' target=_blank style='color:#2F92EE;'>#根尖周炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62192, encryptionId=48786219204, topicName=根尖周炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcae472, createdName=zhangbaojun, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390030, encodeId=7a33139003064, content=<a href='/topic/show?id=2de31e53537' target=_blank style='color:#2F92EE;'>#TLR4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17535, encryptionId=2de31e53537, topicName=TLR4)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F39C49DDAFA7119F6BF29B57B788FE2C/100, createdBy=0ca42500047, createdName=ms3875500703114551, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442852, encodeId=f4101442852ac, content=<a href='/topic/show?id=e112659308a' target=_blank style='color:#2F92EE;'>#淀粉样蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65930, encryptionId=e112659308a, topicName=淀粉样蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1774999170, createdName=ms7405317358118777, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1967954, encodeId=a01a196e95417, content=<a href='/topic/show?id=b8fe1e53318' target=_blank style='color:#2F92EE;'>#TLR2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17533, encryptionId=b8fe1e53318, topicName=TLR2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Feb 24 07:57:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746618, encodeId=29961e4661886, content=<a href='/topic/show?id=989d1e525e5' target=_blank style='color:#2F92EE;'>#TLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17525, encryptionId=989d1e525e5, topicName=TLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd2d35803070, createdName=lilianxiang, createdTime=Wed Aug 21 12:57:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380219, encodeId=b402138021988, content=<a href='/topic/show?id=48786219204' target=_blank style='color:#2F92EE;'>#根尖周炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62192, encryptionId=48786219204, topicName=根尖周炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcae472, createdName=zhangbaojun, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390030, encodeId=7a33139003064, content=<a href='/topic/show?id=2de31e53537' target=_blank style='color:#2F92EE;'>#TLR4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17535, encryptionId=2de31e53537, topicName=TLR4)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F39C49DDAFA7119F6BF29B57B788FE2C/100, createdBy=0ca42500047, createdName=ms3875500703114551, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442852, encodeId=f4101442852ac, content=<a href='/topic/show?id=e112659308a' target=_blank style='color:#2F92EE;'>#淀粉样蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65930, encryptionId=e112659308a, topicName=淀粉样蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1774999170, createdName=ms7405317358118777, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1967954, encodeId=a01a196e95417, content=<a href='/topic/show?id=b8fe1e53318' target=_blank style='color:#2F92EE;'>#TLR2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17533, encryptionId=b8fe1e53318, topicName=TLR2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Feb 24 07:57:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746618, encodeId=29961e4661886, content=<a href='/topic/show?id=989d1e525e5' target=_blank style='color:#2F92EE;'>#TLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17525, encryptionId=989d1e525e5, topicName=TLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd2d35803070, createdName=lilianxiang, createdTime=Wed Aug 21 12:57:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380219, encodeId=b402138021988, content=<a href='/topic/show?id=48786219204' target=_blank style='color:#2F92EE;'>#根尖周炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62192, encryptionId=48786219204, topicName=根尖周炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcae472, createdName=zhangbaojun, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390030, encodeId=7a33139003064, content=<a href='/topic/show?id=2de31e53537' target=_blank style='color:#2F92EE;'>#TLR4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17535, encryptionId=2de31e53537, topicName=TLR4)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F39C49DDAFA7119F6BF29B57B788FE2C/100, createdBy=0ca42500047, createdName=ms3875500703114551, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442852, encodeId=f4101442852ac, content=<a href='/topic/show?id=e112659308a' target=_blank style='color:#2F92EE;'>#淀粉样蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65930, encryptionId=e112659308a, topicName=淀粉样蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1774999170, createdName=ms7405317358118777, createdTime=Mon Sep 24 02:57:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]

相关资讯

Eur Respir J:根据血嗜酸性粒细胞计数,严重过敏性哮喘患者的奥马珠单抗疗效分析!

由此可见,该研究显示大部分SAA患者血嗜酸性粒细胞计数≥300细胞·μL-1,提示奥马珠单抗在“高”和“低”嗜酸性粒细胞亚群中的有效性相似。

感染诊断申请单,SAA求你把他收入编

炎症、感染,当我们大呼“检验集合”的时候,你脑海里赶来报到的队伍中会有谁呢?血常规、C反应蛋白肯定是首当其冲的,可那个有着“S”曲线腰身的新兵你可否熟识呢?人家明明靠着真学实干站进了队伍,却总被当作旁听生地忽视着实让人心中不爽,于是乎他便主动请缨想郑重其事地向大家进行一次自我介绍,那就让我们手巴掌呱唧呱唧热烈欢迎吧……

如何正确使用感染性指标“CRP、PCT、SAA”

感染性疾病是临床常见病、多发病,若不能早期诊断并及时治疗,病情进展可导致脓毒症和多器官功能障碍综合征(MODS),甚至危及生命。感染早期的临床征象常不典型,如何选择高灵敏性、高特异性的的实验室诊断标志物,协助临床医生早期诊断对患者的病情做出快速、准确的诊断具有重要意义。

邵宗鸿:重型再生障碍性贫血患者感染的预防与治疗

作者:天津医科大学总医院 邵宗鸿          重型再生障碍性贫血(SAA)是骨髓造血功能衰竭导致的全血细胞减少综合征,患者出现贫血、感染和出血等症状。由于输血技术的发展,贫血和出血导致SAA患者的死亡逐渐减少,感染导致的死亡成为SAA治疗失败的最主要原因。因此,SAA患者感染的预防与治疗至关重要。    (